Novartis lands in Zurich after Barcelona leg amid US trade headwinds

Novartis flew from Barcelona to Zurich on June 17, landing at LSZH at 18:09 UTC after a 95-minute hop in its Falcon 7X (HB-JFQ). The flight followed a June 15 leg from the New York area to Barcelona, continuing a week that kept the company’s corporate fleet shuttling between the US and Europe.

The same week, Novartis continues to face headwinds from US generics and trade policy. In late April, the company reported a Q1 earnings miss as Entresto sales slumped 42% after patent expiry, per a Marketscreener report, while CEO Vas Narasimhan noted “very constructive” talks with the Swiss government on the US most-favored-nation pricing policy. The Barcelona stop likely involved a visit to Novartis’s R&D presence there, before executives returned to Switzerland for board or strategic meetings.

The trip follows a recent pattern: the jet visited Basel, Boston, and New York in early June before the Barcelona-Zurich swing. With Novartis finalizing a $23 billion US manufacturing expansion, per a GlobeNewswire release, the transatlantic rhythm is unlikely to slow.